QScreen AI Inc. (PMEDF)
| Market Cap | 4.72M +33.3% |
| Revenue (ttm) | n/a |
| Net Income | -857.97K |
| EPS | -0.00 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1 |
| Open | 0.0209 |
| Previous Close | 0.0210 |
| Day's Range | 0.0209 - 0.0214 |
| 52-Week Range | 0.0110 - 0.0670 |
| Beta | 1.76 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 26, 2026 |
About QScreen AI
QScreen AI Inc. develops artificial intelligence powered technologies for general workplace health and safety, and health care industry. It operates through Workplace Health and Safety, and Healthcare segments. The company offers infectious disease symptom screening solutions to identify persons who test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. It also develops alcohol and cannabis impairment detection screening scanners and mental health screening stations; and Mobile Wellbeing, a telemedic... [Read more]
News
QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability
Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - QScreen AI Inc. (CSE: QAI) (OTC: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") today announced completion of the tiered screening architecture at ...
QScreen AI Secures Second US Patent, Extending Single-Camera Impairment Detection on Standard Hardware
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") now holds two granted US patents covering its core impairment-...
QScreen AI Announces Adoption of Semi-Annual Reporting
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, intelligence platform for...
QScreen AI Announces Close of First Tranche of Private Placement
Toronto, Ontario--(Newsfile Corp. - June 25, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, intelligence platform for...
QScreen AI Launches European Investor Roadshow Following Recent Strategic and Technology Milestones
Toronto, Ontario--(Newsfile Corp. - June 1, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announced that membe...
QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S.
Former US Department of Defense AI leader joins QScreen AI after reviewing the platform in person to support institutional commercialization efforts across North America Toronto, Ontario--(Newsfile Co...
QScreen AI Integrates Passive Voice Analysis into Multi-Signal Screening Platform - System Now Reads Physiological, Acoustic, and Behavioral Signals Simultaneously in Real Time
Individual voice baseline established on first encounter, deviation measured on every return visit; no additional hardware required; platform now fully integrated across all three signal modalities To...
QScreen AI Reports Internal Validation Results for Correctional Intake Platform: 100% Sensitivity on Suicide Risk and Withdrawal Detection Across 65 Calibrated Clinical Scenarios
Nine instruments validated against published standards including Columbia C-SSRS, CIWA-Ar, and COWS; paper-only workflow showed materially lower detection rates across the same scenarios; 60-day live ...
QScreen AI Appoints Former Union Pacific Vice President as Strategic Advisor to Drive Expansion into North American Rail and Transportation Markets
Veteran rail executive with 25 years of senior commercial relationships across North America's Class I railroads joins a platform that enables real-time identification of probable drug use from a came...
QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone - Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths
Patent-protected QAI Platform identifies the probable drug class - alcohol, opioids, benzodiazepines, stimulants, or cannabis from physiological camera data and simultaneously administers CIWA-Ar, COW...
QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee ...
QScreen AI Advances Structured Commercial Discussions Following Canadian Trade Mission to Mexico
Toronto, Ontario--(Newsfile Corp. - February 23, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee ...
Qscreen AI Announces Strategic U.S. Engagement to Drive Innovation in Public Safety and Institutional Health
Toronto, Ontario--(Newsfile Corp. - February 9, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), a pioneering leader in artificial intelligence enabled health and safety technology, is...
Predictmedix AI Rebrands as QScreen AI Inc., (QAI) Harnessing Quantum-AI Synergy for Health Screening
Toronto, Ontario--(Newsfile Corp. - January 27, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP0) (formerly Predictmedix AI Inc.), a pioneering leader in artificial intelligence enabled...
CSE Bulletin: Name and Symbol Change - Predictmedix AI Inc. (PMED)
Toronto, Ontario--(Newsfile Corp. - Le 26 janvier/January 2026) - Predictmedix AI Inc. (PMED) has announced a name and symbol change to QScreen AI Inc. (QAI). Shares will begin trading under the new n...
Predictmedix AI Inc. Selected by Canadian Government for Mexico Trade Mission, Led by Minister Dominic LeBlanc, to Drive Growth and High-Value Partnerships
Participation in Canada's official trade mission provides Predictmedix with exclusive, government-facilitated introductions to Mexican distributors, clients, and industry leaders, accelerating interna...
Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare
Toronto, Ontario--(Newsfile Corp. - January 12, 2026) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), excited to announce its proposed name change t...
Predictmedix AI Inc - 2025 Year End Corporate Update
A Defining Year Positioning Predictmedix AI at the Convergence of Quantum, AI, and Healthcare Toronto, Ontario--(Newsfile Corp. - December 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF...
Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and sa...
Predictmedix AI Announces Closing of $460,150 First Tranche
Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and s...
Predictmedix AI Announces Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and sa...
Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform
Adaptive "digital brain" designed to cut risk, cost and timelines in the $70-billion clinical-trials market 1 Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - Predictmedix AI Inc. (CSE: PMED) (O...
Predictmedix AI to Present at the 25th MK Investment Conference in Munich, Germany
TORONTO--(BUSINESS WIRE)--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, is pleased to anno...
Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader
TORONTO--(BUSINESS WIRE)--Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, today outlined a s...
Predictmedix AI Expands into Mobile Diagnostics with New AI-Driven Diabetes Screening Platform
TORONTO--(BUSINESS WIRE)--Predictmedix AI Inc. (CSE: PMED | OTC: PMEDF | FRA: 3QP), a leader in artificial intelligence-driven health screening solutions, is expanding into the direct-to-consumer mark...